Spirocyclic cyclohexane compounds, methods for their production,
pharmaceutical compositions containing these compounds, and the use of
these spirocyclic cyclohexane compounds for treating conditions
associated with the nociceptin/ORL1 receptor system, e.g. pain, drug
withdrawal, anxiety, etc.